Stents Drug Eluting

This channel includes news and new technology innovations for drug eluting stents (DES). This includes both metallic and bioresorbable drug-eluting stents and related clinical trial data.

News | January 07, 2013

January 7, 2013 — Biosensors International has announced enrollment of the first patient in LEADERS FREE, a...

abbott Xience Xpedition stent
Feature | January 03, 2013

January 3, 2013 — Abbott announced that the Xience Xpedition everolimus-eluting coronary stent system received U.S....

2012 Top 10 Advances in Heart Disease and Stroke Research
Feature | December 28, 2012

December 28, 2012 — Resuscitation,...

News | December 20, 2012

December 20, 2012 — The first patient has been enrolled in the Boston Scientific EVOLVE II clinical trial, which is...

Cook, Zilver PTX, stent, expanding, delivery sheath

The Cook Zilver PTX stent expanding from its delivery sheath.

Technology | November 15, 2012

November 15, 2012 — The U.S. Food and Drug Administration (FDA) granted market clearance for Cook Medical’s Zilver...

Boston Scientific Promus Element Plus Promus Element Drug Eluting Stent
News | November 09, 2012

November 9, 2012 — Boston Scientific Corp. has received approval to update the directions for use (DFU) labeling for...

Feature | October 31, 2012

October 31, 2012 — Boston Scientific Corp. received CE mark approval for the Synergy...

News | September 17, 2012

September 17, 2012 — The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first...

News | August 20, 2012

August 20, 2012 — Abbott today announced that the Xience Xpedition...

Feature | July 17, 2012 | Kamran Zamanian, Ph.D.

 

As the average age of the U.S. population and the number of patients at high risk for cardiovascular...

News | June 21, 2012

June 21, 2012 — Plans for a new study involving BioFreedom, the polymer-free drug-coated...

News | June 15, 2012

June 15, 2012 — Stentys SA, a medical technology company commercializing the world's first and only self-apposing...

Feature | June 05, 2012 | Gavin Hays, CEO, Springboard Inc.

Evaluating the performance of your cath lab is key to developing a strategic plan for improving service offerings,...

Technology | June 04, 2012

June 4, 2012 — Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) regulatory approval of...

News | May 30, 2012

May 30, 2012 - According to study results to be featured in the late-breaking clinical trials session at the...

Overlay Init